HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer

FINE FRAGRANCES PLANNING SEPTEMBER U.S. DEBUT FOR DALISSIME

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

FINE FRAGRANCES PLANNING SEPTEMBER U.S. DEBUT FOR DALISSIME women's scent. The "fruity floral" fragrance will be offered in 1,000 perfumery and upscale department stores and promoted in print ads in fall beauty and fashion magazines. First launches for the product will be in Japan, Brazil and France in April; it will be introduced to the rest of Europe in late spring.

Table

View full table

Topics

Tags:
Consumer
Latest Headlines

Clasado, Probi Funded Study Shows Synergistic Effect Of Synbiotic Combination

Qunol Acquisition Gets Sanofi CHC Off To Flying Start

Walmart Lays Out Expectations For Beauty Brands' MoCRA Compliance

US Consumer Health Market People News: Herbalife, Seed Health, Electrolit, Atlas Bars, More

See All
UsernamePublicRestriction

Register

RS000306

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By